Clinical Trial Update: Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of docetaxel and capecitabine in newly diagnosed localized or locally advanced prostate cancer has completed, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Taxotere (docetaxel)
• Xeloda (capecitabine)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED